Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-002595
Filing Date
2025-01-10
Accepted
2025-01-10 17:01:29
Documents
1
Period of Report
2025-01-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm252980-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm252980-2_3seq1.xml 3 1534
  Complete submission text file 0001104659-25-002595.txt   3318
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address PALATIN TECHNOLOGIES, INC. 4B CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
WILLS STEPHEN T (Reporting) CIK: 0001103883 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-12957 | Film No.: 25523813